Summary

GASTROGARD Oral Paste for Equine Ulcers was highly effective at healing gastric ulcers in horses and preventing their recurrence. Efficacy was demonstrated in male and female adult horses and foals in a variety of clinical and field settings. GASTROGARD was well tolerated, and its high acceptance by horses resulted in negligible waste or underdosing. Only GASTROGARD offers these important and unique advantages to equine practitioners, trainers, and owners in the treatment of gastric ulcers:

  • It is a highly effective inhibitor of acid secretion in horses, creating an intragastric environment in which ulcer healing can occur.
  • It is proven to heal and improve ulcers and prevent their recurrence, even during training--not just alleviate their clinical signs.
  • It is the only antiulcer medication for horses that elevates stomach pH throughout the 24 hours after dosing, allowing convenient once-daily dosing.
  • It is the only antiulcerant that has been exhaustively investigated for efficacy and safety in equine use, and the only one approved by the U.S. Food and Drug Administration for this indication.
  • The paste formulation of GASTROGARD has been developed specifically for ease of administration, efficacy, and acceptability in horses.

 

 

 







Glossary

 

 

 

 

 

 

 

 

 

 

 

 

Merial.com   |   EGUS.org  |  Legal Disclaimer   |  Global Home Page
 

 
®GASTROGARD is a registered trademark of AstraZeneca Group of Companies.
Heal the Ulcer and See How They Run is a trademark of Merial.
©2000 Merial Limited. All right reserved